— Know what they know.
Not Investment Advice
Also trades as: 4503.T (JPX) · $vol 92M · ALPMF (OTC) · $vol 0M

ALPMY OTC

Astellas Pharma Inc.
1W: -4.3% 1M: -5.3% 3M: +5.1% YTD: +7.5% 1Y: +29.9% 3Y: +6.2% 5Y: -7.3%
$14.32
-0.12 (-0.83%)
 
Weekly Expected Move ±3.8%
$13 $14 $14 $15 $15
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 44 · $25.7B mcap · 1.79B float · 0.0090% daily turnover · Short 56% of daily vol

📊 Key Metrics

TTM
$2,268B
Revenue
+18.6% YoY
$309B
Net Income
+509.1% YoY
$516B
Free Cash Flow
+227.6% YoY
70.7%
Gross Margin
17.6%
Op. Margin
9.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE18.4%
ROA8.9%
ROIC19.1%

Valuation

P/E11.0
P/B2.1
EV/EBITDA0.0

Leverage

Debt/Equity0.13
Current Ratio1.17
Interest Cov.29.8x

Quality Scores

Piotroski F8/9
Altman Z—
Beneish M-2.42

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms